Press releases

31
Jul 2014
20:30 E.S.T.

Pfizer’s stake in Cellectis’ capital is welcomed by its Shareholders

Read more
29
Jul 2014
20:30 E.S.T.

Cellectis sells its Swedish subsidiary, Cellectis AB, to the Japanese company Takara Bio Inc.

Read more
30
Jun 2014
20:30 E.S.T.

Cellectis SA Combined General Shareholders’ Meeting of June 27, 2014

Read more
23
Jun 2014
20:30 E.S.T.

Cellectis’ UCART19 receives Advanced-Therapy medicinal Product classification from EMA

Read more
18
Jun 2014
20:30 E.S.T.

Pfizer and Cellectis Enter Into Global Strategic Cancer Immunotherapy Collaboration

Read more
9
Jun 2014
20:30 E.S.T.

Cellectis enters into an agreement with CELLforCURE for the cGMP manufacturing of allogeneic CART cells

Read more
5
Jun 2014
20:30 E.S.T.

Cellectis and Thermo Fisher Scientific Enter Into Agreements on TALEN™, a Leading Gene Editing Technology

Read more
5
Jun 2014
20:30 E.S.T.

Cellectis and Accelera (Nerviano Medical Sciences Group) sign an agreement to complete preclinical studies of Cellectis’ lead product candidate UCART19

Read more
29
May 2014
20:30 E.S.T.

Cellectis plant sciences reports improvement of oil content in algae

Read more
23
May 2014
20:30 E.S.T.

Cellectis plant sciences reports generation of High Oleic Soybean in Journal of Plant Biotechnology

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US